Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 1;8(1):404-13.
eCollection 2015.

Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis

Affiliations

Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis

Mona Diab-Assaf et al. Int J Clin Exp Pathol. .

Abstract

Cap dependent translation is mainly regulated at the level of the eukaryotic initiation factor 4E (eIF4E), the activity of which is controlled by phosphorylation and sequestration by its well established regulator, 4E binding protein 1 (4E-BP1). Both eIF4E and 4E-BP1 have been shown to be involved in the malignant progression of multiple human cancers, including colorectal cancer. However, the data on determining the expression of eIF4E, 4E-BP1 and their phosphorylated forms simultaneously in a single patient with colorectal cancer is lacking. Therefore the aim of our study was to explore the roles of these factors in colorectal carcinogenesis by immunohistostaining colorectal tissues (normal, low grade adenoma, high grade adenoma, and adenocarcinoma). Our results showed that the expression levels of eIF4E increased steadily as the cancer progressed from the case of benign dysplasia to an adenocarcinoma; all the while maintaining an unphosphorylated form. On the other hand, total expression levels of 4E-BP1 increased only in the premalignant state of the disease and decreased (but highly phosphorylated or inactivated) or abolished upon malignancy. Taken together, our findings suggest that strong correlations exist between the expression of eIF4E (not p-eIF4E) and tumor grade providing evidence that eIF4E expression plays a pivotal role in the malignant progression of colorectal cancer. Moreover, 4E-BP1 showed a bi-phasic level of expression during carcinogenesis, which is expressed only in hyperplasic or dysplastic tissues as an endogenous tumor suppressor molecule.

Keywords: 4E-BP1; Colorectal cancer; eIF4E; immunuhistochemistry; translational control.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Expression levels of eIF4E in a prototype colorectal tissue with different stage of lesion. A: Normal; B: Low grade adenoma; C: High grade adenoma; D: Adenocarcinoma.
Figure 2
Figure 2
Expression levels of 4E-BP1 in a prototype colorectal tissue with different stage of lesion. A: Normal; B: Low grade adenoma; C: High grade adenoma; D: Adenocarcinoma.
Figure 3
Figure 3
Expression levels of p4E-BP1 in a prototype colorectal tissue with different stage of lesion. A: Normal; B: Low grade adenoma; C: High grade adenoma; D: Adenocarcinoma.
Figure 4
Figure 4
Expression levels of 4E-BP1 and p4E-BP1 in adenocarcinoma tissues. The expression levels of 4E-BP1 (A, C) and the phosphorylated ser65 form (B, D) were showed from two patient samples.

Similar articles

Cited by

References

    1. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics 2014. CA Cancer J Clin. 2014;64:104–117. - PubMed
    1. Merrick WC, Harris ME. Control not at initiation? Bah, humbug! EMBO J. 2014;33:3–4. - PMC - PubMed
    1. Martineau Y, Azar R, Bousquet C, Pyronnet S. Anti-oncogenic potential of the eIF4E-binding proteins. Oncogene. 2013;32:671–6777. - PubMed
    1. Hsieh AC, Ruggero D. Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer. Clin Cancer Res. 2010;16:4914–4920. - PMC - PubMed
    1. Avdulov S, Li S, Michalek V, Burrichter D, Peterson M, Perlman DM, Manivel JC, Sonenberg N, Yee D, Bitterman PB, Polunovsky VA. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell. 2004;5:553–563. - PubMed

Publication types

Substances